From: Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?
Effectiveness
Survival benefit > 3 months
Survival benefit < 3 months, unknown magnitude or no benefit
Total
Study power
Adequately powered
6
2
8
Underpowered
0
4
10